Wharton's Jelly Therapy
Wharton’s jelly is found in the umbilical cord. It is a mucous connective tissue located between the placenta and umbilical vessels.
Wharton's Jelly Therapy
Wharton’s jelly is found in the umbilical cord. It is a mucous connective tissue located between the placenta and umbilical vessels. Wharton’s jelly is a type of stem cell that contains a high concentration of Mesenchymal Stem Cells compared to other tissues.
Wharton’s Jelly Therapy aims to promote natural healing in reducing inflammation and pain. Wharton’s Jelly Therapy is a minimally invasive and safe treatment option.
It is a type of therapy that helps to promote tissue regeneration and reduce inflammation due to its containing elements such as cytokines and growth factors that play a huge role in cellular communication and immune modulation.
Benefits of Wharton’s Jelly Therapy
Enhance healing, reduce inflammation, and support natural tissue regeneration with advanced biologic therapy.
Supports the Natural Healing Response of the Body
Provides regeneration to the damaged cells and tissues
Reduces inflammation and pain
Enhances the collagen production and tissue integrity
Frequently asked questions
Is Wharton's Jelly Therapy safe?
At AHBA, Wharton’s Jelly Therapy is performed by trained medical professionals with a strong focus on patient safety and proper clinical protocols.
Prior to treatment, we conduct a comprehensive assessment, including a detailed medical history and evaluation of your current condition. This ensures that the therapy is appropriate and not contraindicated for you.
What are the conditions that can be treated with Wharton’s Jelly Therapy?
The therapy is used for a wide range of musculoskeletal injuries or conditions. During the consultation, our provider will discuss and determine which treatment or therapy will be suitable for your current condition.
How long does it take to see the results?
Results vary depending on the condition, the body’s ability to respond to healing, and treatment plans discussed. Some patients may notice improvements after the 2 to 3 sessions of the treatment.
Reference
Marino, Luigi et al. “Mesenchymal Stem Cells from the Wharton’s Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential.” International journal of stem cells vol. 12,2 (2019): 218-226. doi:10.15283/ijsc18034
